Alembic Pharmaceuticals Limited (APLLTD) secures USFDA final approval for Venetoclax Tablets, 10 mg, 50 mg, and 100 mg, expanding its generic drug portfolio.
Alembic Pharmaceuticals Limited (APLLTD) secures USFDA final approval for Valganciclovir for Oral Solution, expanding its generic drug portfolio.
Aurobindo Pharma Limited (NSE: AUROPHARMA) receives final approval from USFDA for Perampanel Tablets, set to launch in Q3FY27.
Zydus Lifesciences Limited (ZYDUSLIFE) receives final approval from USFDA for Ascorbic Acid Injection, gaining 180-day CGT exclusivity.
Alembic Pharmaceuticals Limited (APLLTD) receives final approval from USFDA for Tretinoin Cream USP, 0.05%, with an estimated market size of US$ 76 million.
Caplin Point Laboratories Limited (CAPLIPOINT) secures USFDA approval for Foscarnet Sodium Injection, a significant milestone for its subsidiary Caplin Steriles.